Active — Not RecruitingNot Applicable

Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

France100 participantsStarted 2022-03-28

Plain-language summary

The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria : * Patient aged 18 years or older * Diagnosed with head and neck cancer or lung cancer * Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy * Current or former smoker * Patient covered by a social security scheme * Patient informed and having given consent for data collection Patients with human papillomavirus (HPV) may also be included Exclusion Criteria : * Patient receiving palliative treatment * Patient under guardianship or curatorship Study Exit Criteria : \- Protocol-defined exit : After the 12-month consultation Early exit : * Withdrawal of consent for data collection * Death of the patient

What they're measuring

Abstinence at 1 month and 6 months after the end of treatment

Timeframe: 1 and 6 months after the end of treatment.

Trial details

NCT IDNCT06910566

SponsorCentre Oscar Lambret

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11

View on ClinicalTrials.gov More Smoking Cessation trials